Amal Mattu's Top Non-COVID Studies in 2020

COMMENTARY

Amal Mattu's Top Non-COVID Studies in 2020

Amal Mattu, MD

Disclosures

March 01, 2021

0

2020 is finally over. Although the COVID-19 pandemic hasn't ended yet, 2021 has brought some light to the end of the dark tunnel we've all been traveling through. While we might like to completely forget about the past year, it did bring us some excellent emergency medicine literature. The research on SARS-CoV-2 definitely occupied the bulk of our attention, but many other publications unrelated to the virus are worthy of mention as well.

In this annual recap of my favorite articles of the past year, I will focus your attention on three simple but practice-changing articles from 2020, which you may have missed while you were busy treating patients with COVID. Note that these serve as brief summaries only, and I encourage interested readers to peruse the actual articles for further details.

Update to CDC Treatment Guidelines for Gonococcal Infection, 2020

It seems only fitting that we begin this year's summary with a discussion of another infection, Neisseria gonorrhoeae. The authors of this report indicate that gonococcal infections have increased by 63% since 2014. The Centers for Disease Control and Prevention (CDC) have continued to closely monitor prevalence and resistance patterns for N gonorrhoeaeand they have updated their treatment recommendations.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....